PL1820496T3 - Proces wytwarzania urządzenia medycznego do implantacji - Google Patents

Proces wytwarzania urządzenia medycznego do implantacji

Info

Publication number
PL1820496T3
PL1820496T3 PL07001576T PL07001576T PL1820496T3 PL 1820496 T3 PL1820496 T3 PL 1820496T3 PL 07001576 T PL07001576 T PL 07001576T PL 07001576 T PL07001576 T PL 07001576T PL 1820496 T3 PL1820496 T3 PL 1820496T3
Authority
PL
Poland
Prior art keywords
stearate
palmitate
amikacin
tobramycin
gentamicin
Prior art date
Application number
PL07001576T
Other languages
English (en)
Inventor
Klaus-Dieter KÜHN
Sebastian Vogt
Original Assignee
Heraeus Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Medical Gmbh filed Critical Heraeus Medical Gmbh
Publication of PL1820496T3 publication Critical patent/PL1820496T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Physical Vapour Deposition (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Inorganic Insulating Materials (AREA)
PL07001576T 2006-02-15 2007-01-25 Proces wytwarzania urządzenia medycznego do implantacji PL1820496T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007245A DE102006007245A1 (de) 2006-02-15 2006-02-15 Implantatmaterial
EP07001576A EP1820496B1 (de) 2006-02-15 2007-01-25 Verfahren zur Herstellung einer medizinischen Vorrichtung zur Implantation

Publications (1)

Publication Number Publication Date
PL1820496T3 true PL1820496T3 (pl) 2012-03-30

Family

ID=37903579

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07001576T PL1820496T3 (pl) 2006-02-15 2007-01-25 Proces wytwarzania urządzenia medycznego do implantacji

Country Status (14)

Country Link
US (1) US7858109B2 (pl)
EP (1) EP1820496B1 (pl)
JP (1) JP5226956B2 (pl)
CN (1) CN101023926A (pl)
AT (1) ATE527992T1 (pl)
AU (1) AU2007200395B2 (pl)
BR (1) BRPI0700273A (pl)
CA (1) CA2570758C (pl)
DE (1) DE102006007245A1 (pl)
DK (1) DK1820496T3 (pl)
ES (1) ES2374976T3 (pl)
PL (1) PL1820496T3 (pl)
PT (1) PT1820496E (pl)
ZA (1) ZA200701306B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
ES2608695T3 (es) * 2011-06-03 2017-04-12 Waldemar Link Gmbh & Co. Kg Procedimiento para la obtención de un revestimiento de implante e implante correspondiente

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320373B2 (de) 1973-04-21 1978-04-06 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial
DE2651441A1 (de) 1976-11-11 1978-05-24 Merck Patent Gmbh Antibioticahaltiges mittel und seine verwendung als chirurgisches kunststoffmaterial
DE3037270A1 (de) 1980-10-02 1982-05-19 Ulatowski, Lothar, Dr.med., 5630 Remscheid Fibrinantibiotikumverbundketten
DE4404018A1 (de) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
SE9401169L (sv) * 1994-04-08 1995-10-09 Corimed Gmbh Förfarande för framställning av ett antibekteriellt aktivt ämne samt användning därav
US5756127A (en) * 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
DE10114244A1 (de) 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US6648849B2 (en) * 2001-06-27 2003-11-18 Ethicon, Inc. Medicinal implant and device and method for loading and delivering implants containing drugs and cells
DE10262176B4 (de) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung
US7393687B2 (en) * 2004-07-16 2008-07-01 William Marsh Rice University Biomimetic 3-dimensional scaffold with metabolic stream separation for bioartificial liver device

Also Published As

Publication number Publication date
CA2570758A1 (en) 2007-08-15
AU2007200395B2 (en) 2007-11-29
EP1820496A3 (de) 2008-07-09
US20070190109A1 (en) 2007-08-16
DK1820496T3 (da) 2012-01-23
JP5226956B2 (ja) 2013-07-03
CN101023926A (zh) 2007-08-29
JP2007217413A (ja) 2007-08-30
AU2007200395A1 (en) 2007-08-30
US7858109B2 (en) 2010-12-28
ES2374976T3 (es) 2012-02-23
EP1820496B1 (de) 2011-10-12
PT1820496E (pt) 2012-01-13
EP1820496A2 (de) 2007-08-22
ATE527992T1 (de) 2011-10-15
DE102006007245A1 (de) 2007-08-23
CA2570758C (en) 2011-07-19
BRPI0700273A (pt) 2007-11-06
ZA200701306B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
IL186452A0 (en) Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease
MXPA04006731A (es) Sistema de administracion de farmacos que comprenden rapamicina y derivados de la misma para la prevencion y tratamiento de enfermedades vasculares.
WO2006081182A3 (en) Antibacterial agents
WO2007016610A3 (en) Antibacterial agents
WO2007118130A3 (en) Antibacterial agents
WO2006081178A3 (en) Antibacterial agents
HK1111084A1 (en) 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
PL1820496T3 (pl) Proces wytwarzania urządzenia medycznego do implantacji
BR0213398A (pt) Sal de alendronato, alendronato monossódico, processos para a produção dos mesmos, composição farmacêutica, e, método para inibição da ressorção óssea em um paciente
WO2007018886A3 (en) Method of fabricating a bioactive agent-releasing implantable medical device
DE602006019754D1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO2008039917A3 (en) Method for sterilising minocycline- and rifampin-containing medical device
BR0301708A (pt) Preparação farmacêutica com liberação de substância ativas retardada, processo para produção e uso da mesma
BR0213154A (pt) Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos
WO2009055426A3 (en) Random amorphous terpolymer containing lactide and glycolide
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
WO2008097364A3 (en) Use of oritavancin for prevention and treatment of anthrax
AU2012264783B2 (en) Method for producing an implant coating, and corresponding implant
BRPI0511262A (pt) combinação de compostos orgánicos
WO2007010013A3 (en) Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases
EP1910392A4 (en) AZITHROMYCIN CRYSTALLINE L-MALATE MONOHYDRATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
WO2007092930A3 (en) Method of treatment for mycobacterium tuberculosis
WO2006021893A3 (en) Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, fn staphylococcus aureus
AU2021900922A0 (en) Implant device, system and method for treating disease
AU2020900938A0 (en) Implant device, system and method for treating disease